High versus low dose irradiation for tumor immune reprogramming
- 1 October 2020
- journal article
- review article
- Published by Elsevier in Current Opinion in Biotechnology
- Vol. 65, 268-283
Abstract
No abstract availableKeywords
Funding Information
- Ludwig Institute for Cancer Research
This publication has 127 references indexed in Scilit:
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced CancerNew England Journal of Medicine, 2012
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in CancerNew England Journal of Medicine, 2012
- Immunologic Correlates of the Abscopal Effect in a Patient with MelanomaNew England Journal of Medicine, 2012
- Radiation Enhances Regulatory T Cell RepresentationInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2011
- Polarization of Tumor-Associated Macrophages: A Novel Strategy for Vascular Normalization and Antitumor ImmunityCancer Cell, 2011
- Systemic effects of local radiotherapyThe Lancet Oncology, 2009
- Tyrosine dephosphorylation of H2AX modulates apoptosis and survival decisionsNature, 2009
- Matrix Metalloproteinase-9 Is Required for Tumor Vasculogenesis but Not for Angiogenesis: Role of Bone Marrow-Derived Myelomonocytic CellsCancer Cell, 2008
- Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapyNature Medicine, 2007
- Pathogen Recognition and Innate ImmunityCell, 2006